Literature DB >> 17075835

Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.

Lone A Omtvedt1, Louise Royle, Gunnar Husby, Knut Sletten, Catherine M Radcliffe, David J Harvey, Raymond A Dwek, Pauline M Rudd.   

Abstract

OBJECTIVE: To compare the glycosylation of polyclonal serum IgG heavy chains in a patient with rheumatoid arthritis (RA) with that of monoclonal serum IgG heavy chains in the same patient during an episode of heavy-chain deposition disease (HCDD), to establish whether glycosylation processing is specific for subsets of B cells.
METHODS: Serum IgG was purified using a HiTrap protein G column. Immunoglobulins were run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, and IgG glycans were isolated from gel bands and fluorescently labeled. Glycans were analyzed by normal-phase high-performance liquid chromatography and by liquid chromatography-electrospray ionization-mass spectrometry.
RESULTS: The glycosylation of serum immunoglobulins from a patient with seronegative RA and HCDD was analyzed. The predominant immunoglobulin was a truncated glycosylated gamma3 heavy chain, and a small amount of polyclonal IgG was also present. The glycan profile showed that the monoclonal gamma3 heavy chain contained fully galactosylated biantennary glycans with significantly less fucose but more sialic acid than in IgG3 from healthy controls. In contrast, the polyclonal IgG showed an RA-like profile, with a predominance of fucosylated biantennary glycans and low levels of galactosylation. The glycan profile of serum IgG obtained from the same patient during disease remission resembled a typical RA profile.
CONCLUSION: These data indicate that different types of B cells process a particular set of IgG glycoforms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075835     DOI: 10.1002/art.22171

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

Review 1.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

2.  Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Authors:  Jun Wang; Crina I A Balog; Kathrin Stavenhagen; Carolien A M Koeleman; Hans Ulrich Scherer; Maurice H J Selman; André M Deelder; Tom W J Huizinga; René E M Toes; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

3.  Kinetics of N-Glycan Release from Human Immunoglobulin G (IgG) by PNGase F: All Glycans Are Not Created Equal.

Authors:  Yining Huang; Ron Orlando
Journal:  J Biomol Tech       Date:  2017-10-09

4.  Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Authors:  Altan Ercan; Michael G Barnes; Melissa Hazen; Heather Tory; Lauren Henderson; Fatma Dedeoglu; Robert C Fuhlbrigge; Alexei Grom; Ingrid A Holm; Mark Kellogg; Susan Kim; Barbara Adamczyk; Pauline M Rudd; Mary Beth Son; Robert P Sundel; Dirk Foell; David N Glass; Susan D Thompson; Peter A Nigrovic
Journal:  Arthritis Rheum       Date:  2012-09

Review 5.  The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.

Authors:  Kimberly A Thomas; Nicole M Valenzuela; Elaine F Reed
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

6.  The N-glycome of human plasma.

Authors:  Katherine A Stumpo; Vernon N Reinhold
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

Review 7.  Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses.

Authors:  L Renee Ruhaak; Gege Xu; Qiongyu Li; Elisha Goonatilleke; Carlito B Lebrilla
Journal:  Chem Rev       Date:  2018-03-19       Impact factor: 60.622

8.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

9.  Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Authors:  Dimitra Sasaroli; George Coukos; Nathalie Scholler
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

10.  High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Authors:  Hao D Cheng; Henning Stöckmann; Barbara Adamczyk; Ciara A McManus; Altan Ercan; Ingrid A Holm; Pauline M Rudd; Margaret E Ackerman; Peter A Nigrovic
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.